These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia. Ulrich S, Neuhof S, Braun V, Meyer FP. Int Clin Psychopharmacol; 1999 Jul; 14(4):219-28. PubMed ID: 10468314 [Abstract] [Full Text] [Related]
4. In vitro characterization of the oxidation of a pyridinium metabolite of haloperidol by human placenta: the effect of smoking. Fang J, Song J. J Pharm Pharm Sci; 2012 Jul; 15(4):538-47. PubMed ID: 23106957 [Abstract] [Full Text] [Related]
11. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T, Perry CM. Drugs; 2004 Sep 19; 64(15):1715-36. PubMed ID: 15257633 [Abstract] [Full Text] [Related]
18. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W. Int J Neuropsychopharmacol; 2008 Nov 19; 11(7):985-97. PubMed ID: 18466670 [Abstract] [Full Text] [Related]
19. Risperidone in treatment-refractory schizophrenia. Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC. Am J Psychiatry; 1999 Sep 19; 156(9):1374-9. PubMed ID: 10484947 [Abstract] [Full Text] [Related]